Onesource Specialty Pharma Ltd.

•

onesourcecdmo.comBSE: 544292NSE: ONESOURCE

Market Cap₹ 18,261 Cr.

Current Price

High / Low₹ 1,925 / 1,057

Stock P/E383.5

Book Value₹ 523

Price to Book2.84

Dividend Yield0.00 %

ROCE2.0 %

ROE0.4 %

Face Value₹ 1

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Contract Development and Manufacturing Organization: 100.0%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Operating margins have improved to 16.7% from -407.9%
Latest quarter profit grew 106.4% YoY, showing strong momentum
Working capital cycle has improved - days down from -13 to -17
Institutional investors have been accumulating - FII+DII up 5.9pp
Company maintains a comfortable, low leverage position

CONS

A large part of profit comes from other income (221.3% of PBT)
Recent results are weak - TTM profit is down 85.3% versus prior year
Receivables are growing faster than sales - a possible quality concern
Company has a low return on equity of -20.5% over last 3 years
Company has a low return on capital employed of -5.2%
Interest coverage is weak at 1.2x - earnings barely cover interest

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY TOTAL MKT NIFTY 500 NIFTY SMLCAP 250

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	ONESOURCE	1592.40	383.46	18260.51	0.00	25.00	13539.25	449.02	37.20	0.44	27.47

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	34	56	73	240	245	337	477	321	375	290	419	446
	72	67	76	230	222	237	240	241	274	277	344	399
Operating Profit	-38	-10	-3	10	23	99	237	80	102	13	75	47
OPM %	-113.32%	-18.38%	-3.65%	4.27%	9.35%	29.54%	49.63%	24.88%	27.07%	4.42%	17.83%	10.63%
	-5	-105	3	-1	-3	-95	4	5	3	-2	4	4
Interest	25	26	20	41	44	44	32	27	33	38	22	31
Depreciation	18	20	20	34	33	34	34	33	34	35	35	36
Profit before Tax	-87	-161	-40	-65	-58	-73	175	25	37	-62	21	51
Tax %	-0.00%	-0.00%	-0.00%	63.38%	-0.00%	-0.00%	0.00%	0.00%	0.00%	-0.00%	0.00%	0.00%
Net Profit	-87	-161	-40	-24	-58	-73	175	25	37	-62	21	51
	-27.30	-38.66	-9.63	-2.22	-5.35	-6.69	15.28	2.17	3.24	-5.43	1.87	4.47

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	39	172	1,300	1,405	1,531
	199	259	932	1,168	1,294
Operating Profit	-161	-88	367	237	237
OPM %	-414.89%	-50.91%	28.26%	16.87%	15.45%
	-156	-112	-93	42	8
Interest	48	89	162	121	124
Depreciation	66	76	135	137	140
Profit before Tax	-430	-365	-21	21	48
Tax %	-0.00%	-0.00%	193.22%	0.00%	0.00%
Net Profit	-430	-365	20	21	48
EPS	-200.69	-91.01	1.75	1.85	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: 231%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: -14%

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: -20%
Last Year:: 0%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4	4	11	11
	777	386	5,896	5,932
	858	414	866	1,360
Trade Payables	95	81	160	402
	275	424	456	570
Total Liabilities	2,008	1,309	7,390	8,276
	1,361	863	3,200	3,198
Capital Work in Progress	191	43	60	314
	5	20	2,848	2,931
	133	11	153	439
	0	55	442	735
Cash & Bank	80	60	228	90
	238	257	459	569
Total Assets	2,008	1,309	7,390	8,276

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-176	-109	-47	55
Cash from Investing	-66	506	-300	-478
Cash from Financing	118	-384	417	361
	-112	13	70	-61

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	37.77	34.25	29.79	29.77	29.93	30.48	30.48
	17.44	18.54	18.69	19.39	19.24	17.50	19.19
	12.43	17.90	17.96	18.35	18.67	20.61	23.37
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	32.36	29.30	33.55	32.48	32.15	31.41	26.94

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11

Updates

2026-09-11 - Onesource Specialty Pharma Limited has informed the Exchange regarding 'Addendum to the notice of the 19th AGM scheduled to be held on September 23, 2026

2026-09-03

Investor Presentation

2026-09-03 - Onesource Specialty Pharma Limited has informed the Exchange about Investor Presentation

2026-09-01

Copy of Newspaper Publication

2026-09-01 - Onesource Specialty Pharma Limited has informed the Exchange about Copy of Newspaper Publication confirming dispatch of Notice of the 19th Annual GeneralMeeting (AGM) and Remote e-voting

2026-08-31

Updates

2026-08-31 - Onesource Specialty Pharma Limited has informed the Exchange regarding 'Intimation of Business Responsibility and Sustainability Report for FY 25-26'.

2026-08-31

Shareholders meeting

2026-08-31 - Onesource Specialty Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026

2026-08-31

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-31 - Onesource Specialty Pharma Limited has informed the Exchange about Schedule of meet

2026-08-29

Copy of Newspaper Publication

2026-08-29 - Onesource Specialty Pharma Limited has informed the Exchange about Copy of Newspaper Publication regarding the 19th AGM of the Company

2026-08-18

Credit Rating

2026-08-18 - Onesource Specialty Pharma Limited has informed the Exchange about Credit Rating

2026-07-31

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-31 - OneSource Specialty Pharma Limited has informed the Exchange about Earnings Call Transcript dated July 25, 2026

News

Recent coverage and analyst commentary for ONESOURCE

Loading news…

🤖

AI Stock Analyst

Onesource Specialty Pharma Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

ONESOURCE

1592.40

383.46

18260.51

0.00

25.00

13539.25

449.02

37.20

0.44

27.47

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

240

245

337

477

321

375

290

419

446

230

222

237

240

241

274

277

344

399

Operating Profit

-38

-10

-3

237

102

OPM %

-113.32%

-18.38%

-3.65%

4.27%

9.35%

29.54%

49.63%

24.88%

27.07%

4.42%

17.83%

10.63%

-5

-105

-1

-3

-95

-2

Interest

Depreciation

Profit before Tax

-87

-161

-40

-65

-58

-73

175

-62

Tax %

-0.00%

63.38%

-0.00%

0.00%

-0.00%

0.00%

Net Profit

-87

-161

-40

-24

-58

-73

175

-62

-27.30

-38.66

-9.63

-2.22

-5.35

-6.69

15.28

2.17

3.24

-5.43

1.87

4.47

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

172

1,300

1,405

1,531

199

259

932

1,168

1,294

Operating Profit

-161

-88

367

237

OPM %

-414.89%

-50.91%

28.26%

16.87%

15.45%

-156

-112

-93

Interest

162

121

124

Depreciation

135

137

140

Profit before Tax

-430

-365

-21

Tax %

-0.00%

193.22%

0.00%

Net Profit

-430

-365

EPS

-200.69

-91.01

1.75

1.85

—

Dividend Payout %

0.00%

—

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

777

386

5,896

5,932

858

414

866

1,360

Trade Payables

160

402

275

424

456

570

Total Liabilities

2,008

1,309

7,390

8,276

1,361

863

3,200

3,198

Capital Work in Progress

191

314

2,848

2,931

133

153

439

442

735

Cash & Bank

228

238

257

459

569

Total Assets

2,008

1,309

7,390

8,276

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-176

-109

-47

Cash from Investing

-66

506

-300

-478

Cash from Financing

118

-384

417

361

-112

-61

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

37.77

34.25

29.79

29.77

29.93

30.48

17.44

18.54

18.69

19.39

19.24

17.50

19.19

12.43

17.90

17.96

18.35

18.67

20.61

23.37

Government

0.00

32.36

29.30

33.55

32.48

32.15

31.41

26.94

Onesource Specialty Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Onesource Specialty Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI